製品の概要

  • 製品名
    Nicotinic acid (Niacin)
  • 製品の詳細
    Antidyslipidemic agent
  • 別名
    • Niacin
    • vitamin B3
  • 生理活性の詳細
    Antidyslipidemic. Increases high-density- and lowers low-density lipoproteins. Putative ligand for the HM74A receptor.
  • 精製度
    > 98%

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab120145 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
Functional Studies Use at an assay dependent concentration.

画像

  • ab64308 staining ApoA1 in HepG1 cells treated with nicotinic acid (ab120145), by ICC/IF. Decrease in ApoA1 expression correlates with increased concentration of nicotinic acid, as described in literature.
    The cells were incubated at 37°C for 72h in media containing different concentrations of ab120145 (nicotinic acid) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab64308 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.

参考文献

This product has been referenced in:

See 0 Publications for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab120145.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

登録